Liesl Zühlke is an expert in Cardiology at Red Cross War Memorial Children's Hospital (South Africa). As of October 2026, ScienceLeadR ranks Liesl Zühlke in the top 1% of experts worldwide for Rheumatic Heart Disease, and in the top 1% of experts in South Africa for Cardiovascular Abnormalities and Congenital Abnormalities. Liesl Zühlke has authored 265 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 1 of them ongoing. SLR score: 994 (community average: 125). How the SLR is computed.

LeadR Profile

994 ScienceLeadR Reputation 994
Network Map

Cardiology

Subspecialties: Public Health - Pediatrics - Infectiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2012 - 2026

Source: PubMed

University of Cape Town

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 265

Citations

Citations: 76 932 1st author: 28 Last author: 47 Unique author: 5


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Stakeholder perspectives on the feasibility and uptake of the cardiovascular polypill in South Africa.
PMID 42699462 — antihypertensive agents, research, single-pill combination
J Public Health Afr20260
SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease.
PMID 42233563 — heart valve diseases, epidemiology, heart diseases, mitral valve, heart, rheumatic heart disease, therapeutics
JACC Asia20260
Snippets from the 28th Congress of the South African Society for Biochemistry and Molecular Biology.
PMID 42213319 — biochemistry, molecular biology
Adv Exp Med Biol20260
Diagnostic Yield of Exome Sequencing in Patients With Congenital Heart Disease From Southern Africa.
PMID 42037320 — heart defects, congenital, genes, heart diseases, heart, phenotype, morbidity, exome, child
Circ Genom Precis Med20260
Early rheumatic heart disease is a recognized intermediate on the pathway to advanced rheumatic heart disease.
PMID 41833866 — heart diseases, heart, rheumatic fever, cardiology, rheumatic heart disease, history
Int J Cardiol20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 2 1
Phase 2/Phase 3 1
Phase 3 1

By status:

Completed 3
Recruiting 1
Unknown 1

By type:

Interventional 3
Observational 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
National Blood Pressure Screening in Children to Improve Paediatric Healthcare in South Africa
NCT05982847 — research design, hypertension, life style, blood, pediatric obesity, insemination, artificial, heterologous, nomograms, cardiovascular diseases, blood pressure, adiposity, health knowledge, attitudes, practice, adolescent, obesity, child
N/ARecruiting2024

LeadR Networks

Main global connection map